Long-term effects of aromatase inhibitors on bone
- 31 May 2005
- journal article
- review article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 95 (1-5), 151-154
- https://doi.org/10.1016/j.jsbmb.2005.04.009
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical TrialJournal of Clinical Endocrinology & Metabolism, 2002
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Comparison of Effects of Tamoxifen and Toremifene on Bone Biochemistry and Bone Mineral Density in Postmenopausal Breast Cancer PatientsJournal of Clinical Endocrinology & Metabolism, 1998
- Evidence that Tamoxifen Preserves Bone Density in Late Postmenopausal Women with Breast CancerActa Oncologica, 1998
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal womenAmerican Journal Of Medicine, 1995
- Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.Journal of Clinical Oncology, 1994
- Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal womenBone and Mineral, 1993